cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Illumina Inc
88 own
55 watching
Current Price
$111.07
$-3.39
(-2.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
17,574.27M
52-Week High
52-Week High
213.91000
52-Week Low
52-Week Low
89.00000
Average Volume
Average Volume
1.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
68.9243
iconMarket Capitalization17,574.27M
icon52-Week High213.91000
icon52-Week Low89.00000
iconAverage Volume1.04M
iconDividend Yield--
iconP/E Ratio68.9243
What does the Illumina Inc do?
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company's sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has collaboration agreements with IBM Watson Health to access genome data interpretation by integrating Watson for genomics into Illumina's BaseSpace Sequence Hub and tumor sequencing process; and NRGene to develop new molecular breeding tools for cattle to support global food production. The company also has a co-development agreement with Munich Leukemia Laboratory GmbH and IBM Watson Health to build a cognitive technology prototype to help researchers improve leukemia treatment. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Read More
How much money does Illumina Inc make?
News & Events about Illumina Inc.
Benzinga
10 months ago
read more...
GuruFocus
11 months ago
Illumina and Natera are category leaders with strong competitive moatsRelated Stocks: ILMN, NTRA, NSTG, TXG...
Invezz News
11 months ago
Illumina Inc (NASDAQ: ILMN), on Sunday, said its board has accepted resignation from CEO Francis deSouza whos been leading the gene sequencing company since 2016. Charles Dadswell named interim CEO The biotech giant has already started looking or a new chief executive. Both internal as well ...
Fortune
11 months ago
Icahn has faced his own activist challenges, with Hindenburg Research questioning the value of his investment firm.Icahn has faced his own activist challenges, with Hindenburg Research questioning the value of his investment firm. Read More...
Seattle Times: Business & Technology
11 months ago
Gene sequencing test maker Illumina Inc. says its board has accepted the resignation of its CEO and director, Francis deSouza, effective immediately...
Frequently Asked Questions
Frequently Asked Questions
What is Illumina Inc share price today?
plus_minus_icon
Can Indians buy Illumina Inc shares?
plus_minus_icon
How can I buy Illumina Inc shares from India?
plus_minus_icon
Can Fractional shares of Illumina Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Illumina Inc stocks?
plus_minus_icon
What is today’s traded volume of Illumina Inc?
plus_minus_icon
What is today’s market capitalisation of Illumina Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Illumina Inc?
plus_minus_icon
What percentage is Illumina Inc down from its 52-Week High?
plus_minus_icon
What percentage is Illumina Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$111.07
$-3.39
(-2.96%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00